Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia
Clinical trial NCT02244242 · COMPLETED
Trial details
- NCT number
- NCT02244242
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 1998-07-01
- Primary completion
- 1999-08-01
- Enrollment
- 493
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.